drugset / Trial / NCT04018157

Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries

NCT04018157

Phase 0 Completed 150 enrolled Zagazig University
RandomizedParallel-groupDouble-blindPrevention

Summary

* emergence agitation is seen in around 68% after nasal surgeries. Agitated patients needs more staff and nurses to control their abnormal movement which leads to self extubation , removal of catheters and bruises in the extremities. * Dexmedetomidine, ketamine, propofol intravenous infusion and other agents was used to prevent EA . Recently, ketodex is found to reduce the incidence and severity of EA . * We aim to compare single bolus dose of Ketodex Versus Ketofol For Prevention Of emergence Agitation in adults undergoing nasal surgeries.

Timeline

Start
2019-07-03
Primary completion
2019-11-20
Completion
2019-11-23

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 1 ug/kg Intravenous
Comparator Ketamine Small molecule 0.5 mg/kg Intravenous
Comparator Propofol Small molecule Intravenous

Indications

No indication recorded.